Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-15

Study Completion Date

2034-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe childhood obesity is associated with both immediate and chronic health problems and a severe impact on psychosocial development. Medical and behavioural interventions rarely result in the significant, durable weight loss necessary to improve health outcomes.

This is a randomised clinical trial where 50 adolescents, 13-16 years of age, will be randomised to either early bariatric surgery (Roux-en-Y gastric bypass) or intense conservative treatment and possibly surgery after two years of non-surgical treatment or as they have become 18 years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Laparoscopic Adjustable Gastric Banding in Adolescents

NCT01619488

Morbid Obesity

COMPLETED NA

Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents

NCT00592202

Morbid Obesity

COMPLETED NA

Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates

NCT00721227

Obesity

COMPLETED NA

Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity

NCT03273855

Obesity, Morbid

UNKNOWN NA

Effectiveness Gastric Balloon in Obese Adolescents

NCT04209842

Obesity, Morbid

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multicentre randomised clinical trial where three tertiary referral hospitals recruit patients.

Patients and their parents receive information about the study at their paediatric clinic and at the trial web page (www.amos2.se). Standardised procedure, including signed informed consent.

Interventions

At the end of day of baseline examination patients are randomised to either of two arms:

* Bariatric surgery with regular follow up
* Optimised conservative treatment starting with an 8-week Low Calorie Diet period followed by tailored support and treatment by the multidisciplinary team with an intensity of at least one visits a month over at least 2 years

Patients in the conservative arm will be reassessed regarding interest of undergoing bariatric surgery two years after inclusion.

Sample Size A sample size of 50 (25+25) leaves a power of more than 95% to evaluate a possible superiority of \>10% weight difference between the two groups, assuming a 15% standard deviation in weight loss over follow-up at 2.5% significance level.

This number also allows assessment for differences in cardiovascular risk factors with sufficient power and acceptable power for demonstrating differences in quality of life and cognitive functions.

3.6 Randomization The computerized random allocation is performed during the day of baseline examination and patients were informed of their assignment. Forty-nine patients have been included until May 2017, and the last patient will be operated on June 14th. Stratification has been performed according to the recruitment centre

3.8 Statistical Methods \& Additional Analyses Safety \& Efficacy Outcomes: Analyses will be by intention to treat, including all randomised patients. Difference in treatment effect will be evaluated with hazard ratio between the treatment groups, and the corresponding confidence interval will be calculated. For secondary outcomes, the incidence of comorbidities during follow-up will be evaluated using time-to-event models, and for continuous variables mixed models will be used to evaluate differences between the treatment groups.

Incremental cost-effectiveness analysis will be conducted by calculating the incremental cost-effectiveness ratio (ICER; dividing the between-group difference in costs with the between-group difference in quality-adjusted life-years (QALYs) as well as life-years). Probabilistic sensitivity analysis will be conducted and results presented in an ICER scatterplot and cost-effectiveness acceptability curve.

Follow-Up Clinical Data Collection: Study point are 6 weeks, 1 year, 2 years, and 5 years after the start of intervention. Weight, quality of life, and adverse events, as well as clinical data regarding treatments for co-morbidities. Blood sampling for assessment of nutritional deficiencies, glucose control, blood lipids and inflammation will be collected at baseline and 1, 2 and 5 years.

Cognitive functions: Assessments will be performed at baseline and 1 and 2 years after start of intervention.

Register-Based Data Collection and Health-Economic Outcomes: Collection and analysis of Swedish national health care and other official registries

We decided in the Study Steering Committee to change time points for long term follow up to be 5, 10 and 15 years after treatment initiation to better comply with standard schedules for clinical follow up in registers (instead of 7, 12 and 17y after treatment initiation).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Diabetes Hypertension Steatohepatitis Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomisation between Bariatric surgery (mainly Roux-en-Y gastric bypass) or Intensive Medical treatment

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bariatric surgery

Roux-en-Y gastric bypass surgery

Group Type EXPERIMENTAL

Laparoscopic Roux-en-Y gastric bypass

Intervention Type PROCEDURE

Bariatric surgery with Roux-en-Y gastric bypass as preferred option, possible laparoscopic Vertical Sleeve Gastrectomy

Intense conservative treatment

Intense conservative treatment. 8 week LCD followed by outpatient visits 1/ month

Group Type ACTIVE_COMPARATOR

Intense conservative treatment

Intervention Type PROCEDURE

Intense medical treatment for obesity (behavioral treatment, dietary intervention, exercise, medication etc) 8 week period of Low Calorie Diet. Treatment intensity about 1 visit a month over 2 years

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic Roux-en-Y gastric bypass

Bariatric surgery with Roux-en-Y gastric bypass as preferred option, possible laparoscopic Vertical Sleeve Gastrectomy

Intervention Type PROCEDURE

Intense conservative treatment

Intense medical treatment for obesity (behavioral treatment, dietary intervention, exercise, medication etc) 8 week period of Low Calorie Diet. Treatment intensity about 1 visit a month over 2 years

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 13-16 years
* BMI \>35
* Failed comprehensive treatment for obesity \> 1 year
* Passing assessment of psychologist
* Tanner 3 or more

Exclusion Criteria

* Monogenic obesity (for example Prader Willis, Laurence Moon-Bardet-Biedl)
* Obesity secondary to brain injury
* Severely mentally disabled
* Not eligible for general anesthesia
* Psychotic or other major psychiatric illness
* Previous major gastrointestinal surgery

Minimum Eligible Age

13 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No